CM

Cyriac Mathew Palamthattel

Director Director DIN 03069975
DIN 03069975 First appointment Jul 2010 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Jul 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Cyriac Mathew Palamthattel

Data last updated:

Cyriac Mathew Palamthattel has 16 years in corporate governance. Formerly with 1 company, such as Zenobia Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03069975
Primary Designation Director
First Appointment 23 Jul 2010
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director23 Jul 20102010₹68.7 Lakh (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zenobia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Cyriac Mathew Palamthattel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cyriac Mathew Palamthattel

Cyriac Mathew Palamthattel has 16 years in corporate governance. Formerly with 1 company, such as Zenobia Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Cyriac Mathew Palamthattel has expertise in General Business.

Cyriac Mathew Palamthattel has 16 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available